FDA Approves A new Drug For Nocturnal Polyuria (Frequent Urination At Night)

                  FDA Approves A new Drug For Nocturnal Polyuria FDA approves a new drug for Nocturnal polyuria

FDA Approves New Drug For Nocturnal Polyuria (Frequent Urination  At Night)

Good News:US FDA  Approves A New Drug  For Nocturnal Polyuria In Adults i.e Noctiva, That Will Control Your Frequent Urination At Night.The Drug Is In Nasal Spray Form And Will Only Be used For Adult Nocturnal Enuresis.

The active ingredient in Noctiva Spray Is desmopressin acetate, is included in some other medicine, as well as an injected version for bleeding disorders. The FDA said the nasal spray version is that the first approved treatment for frequent nighttime urination.

An Official From FDA’s Center for Drug evaluation and research said during a statement on Friday said, “Today’s approval provides adults who overproduce pee at midnight with the primary FDA-approved therapeutic option tofacilitate reduce the amount of times a night they get up to urinate”. The Food and Drug Administration Further said the spray, referred to as Noctiva, isn’t approved to treat all causes of frequent nighttime urination, thus doctors should confirm the cause and best treatment for each person.

Actually The Spray Is Originally Approved For A Common Condition Caused By Uncontrolled Diabetes ,Chronic Heart Failure (CHF), Prostate And Bladder Problems.

Noctiva’s effectiveness was Checked in randomized, placebo-controlled trials in 1,045 patients 50 years elderly and older with nocturia because of nocturnal polyuria. though these trials showed alittle reduction within the average range of night-time urinations with Noctiva compared to placebo, a lot of patients treated with Noctiva were able to at least halve their range of night-time urinations, and patients treated with Noctiva had more nights with one or fewer night-time urinations.

How To Use The Spray:

The nasal spray is employed daily about half-hour before bedtime. It works by making the kidneys absorb a lot of water, that reduces the quantity of urine.

FDA’s strongest Black Box  warning :

The drug will cause hazardously low levels of sodium within the blood (Hyponatremia). alternative side effects include increased blood pressure, colds, dizziness, bronchitis, nose bleeds,And back pain.

Milford ,Pennsylvania-based Renaissance Lakewood, LLC for Serenity Pharmaceuticals, LLC Has Marketed The Noctiva Spray.


One Reply to “FDA Approves A new Drug For Nocturnal Polyuria (Frequent Urination At Night)”

Leave a Reply

Your email address will not be published. Required fields are marked *

nineteen − two =